Background: In the last decade, several observational studies have suggested that there exists an association between periodontal disease (PD) and Alzheimer's disease (AD). The aim of this systematic review was to investigate whether or not this link exists. Summary: The Preferred Reporting Items for Systematic Reviews and Meta-Analysis guideline for systematic review was used and registered at PROSPERO (CRD42016035377). The search strategy included using electronic databases and by hand searching articles published up to January 2016. MEDLINE via PubMed, EMBASE and Web of Science were searched by 2 independent reviewers. Observational studies including patients meeting criteria for both AD and PD were eligible to be included in the analysis. Quality assessment of selected studies was performed by the Newcastle-Ottawa Scale. From a total of 550 titles and abstracts, 5 studies were included (2 cross-sectional, 2 case-control and one cohort study) in the review. A fixed effects meta-analysis showed that the presence of PD is associated with the presence of AD (OR 1.69, 95% CI 1.21-2.35). When only severe forms of PD were evaluated, a significant association was also observed (OR 2.98, 95% CI 1.58-5.62). Key Messages: In the present review, a significant association was observed between PD and AD. Further studies should be carried out in order to investigate the direction of the association and factors that may confound it.

Keywords:
Periodontitis, Alzheimer’s disease, Periodontal disease, Dementia, Review, Meta-analysis
1.
Albandar JM, Rams TE: Global epidemiology of periodontal diseases: an overview. Periodontol 2000 2002;29:7-10.
2.
Demmer RT, Papapanou PN: Epidemiologic patterns of chronic and aggressive periodontitis. Periodontol 2000 2010;53:28-44.
3.
Pihlstrom BL, Michalowicz BS, Johnson NW: Periodontal diseases. Lancet 2005;366:1809-1820.
4.
Querfurth HW, LaFerla FM: Alzheimer's disease. N Engl J Med 2010;362:329-344.
5.
Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al: Alzheimer's Disease International: Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366:2112-2117.
6.
Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E: Alzheimer's disease. Lancet 2011;377:1019-1031.
7.
Galimberti D, Scarpini E: Progress in Alzheimer's disease. J Neurol 2012;259:201-211.
8.
Kamer AR, Dasanayake AP, Craig RG, Glodzik-Sobanska L, Bry M, de Leon MJ: Alzheimer's disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesis. J Alzheimers Dis 2008;13:437-449.
9.
Kamer AR, Craig RG, Dasanayake AP, Brys M, Glodzik-Sobanska L, de Leon MJ: Inflammation and Alzheimer's disease: possible role of periodontal diseases. Alzheimers Dement 2008;4:242-250.
10.
Syrjälä AM, Ylöstalo P, Ruoppi P, Komulainen K, Hartikainen S, Sulkava R, et al: Dementia and oral health among subjects aged 75 years or older. Gerodontology 2012;29:36-42.
11.
Martande SS, Pradeep AR, Singh SP, Kumari M, Suke DK, Raju AP, et al: Periodontal health condition in patients with Alzheimer's disease. Am J Alzheimers Dis Other Demen 2014;29:498-502.
12.
Gil-Montoya JA, Sanchez-Lara I, Carnero-Pardo C, Fornieles F, Montes J, Vilchez R, et al: Is periodontitis a risk factor for cognitive impairment and dementia? A case-control study. J Periodontol 2015;86:244-253.
13.
Uppoor AS, Lohi HS, Nayak D: Periodontitis and Alzheimer's disease: oral systemic link still on the rise? Gerodontology 2013;30:239-242.
14.
Wu Z, Nakanishi H: Connection between periodontitis and Alzheimer's disease: possible roles of microglia and leptomeningeal cells. J Pharmacol Sci 2014;126:8-13.
15.
Shaik MM, Ahmad S, Gan SH, Abuzenadah AM, Ahmad E, Tabrez S, et al: How do periodontal infections affect the onset and progression of Alzheimer's disease? CNS Neurol Disord Drug Targets 2014;13:460-466.
16.
Gaur S, Agnihotri R: Alzheimer's disease and chronic periodontitis: is there an association? Geriatr Gerontol Int 2015;15:391-404.
17.
Egger M, Davey Smith G, Altman DG: Systematic Reviews in Health Care. Meta-Analysis in Context 212. London, BMJ Publishing Group, 2003.
18.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009;62:e1-e34.
19.
Armitage GC: Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
20.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
21.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, The Association, 2000.
22.
Folstein MF, Folstein SE, Mchugh PR: ‘‘Mini-mental state''. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
23.
Stang A: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603-605.
24.
Takkouche B, Cadarso-Suárez C, Spiegelman D: Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. Am J Epidemiol 1999;150:206-215.
25.
Costa-Bouzas J, Takkouche B, Cadarso-Suárez C, Spiegelman D: HEpiMA: software for the identification of heterogeneity in meta-analysis. Comput Methods Programs Biomed 2001;64:101-107.
26.
Ship JA, Puckett SA: Longitudinal study on oral health in subjects with Alzheimer's disease. J Am Geriatr Soc 1994;42:57-63.
27.
de Souza Rolim T, Fabri GM, Nitrini R, Anghinah R, Teixeira MJ, de Siqueira JT, et al: Oral infections and orofacial pain in Alzheimer's disease: a case-control study. J Alzheimers Dis 2014;38:823-829.
28.
Dietrich T, Sharma P, Walter C, Weston P, Beck J: The epidemiological evidence behind the association between periodontitis and incident atherosclerotic cardiovascular disease. J Periodontol 2013;84(4 suppl):S70-S84.
29.
Borgnakke WS, Ylöstalo PV, Taylor GW, Genco RJ: Effect of periodontal disease on diabetes: systematic review of epidemiologic observational evidence. J Clin Periodontol 2013:84:S135-S152.
30.
Scannapieco FA, Ho AW: Potential associations between chronic respiratory disease and periodontal disease: analysis of national health and nutrition examination survey III. J Periodontol 2001;72:50-56.
31.
Leira Y, Seoane J, Blanco M, Rodríguez-Yáñez M, Takkouche B, Blanco J, et al: Association between periodontitis and ischemic stroke: a systematic review and meta-analysis. Eur J Epidemiol 2016, Epub ahead of print.
32.
Leira Y, López-Dequidt I, Arias S, Rodríguez-Yáñez M, Leira R, Sobrino T, et al: Chronic periodontitis is associated with lacunar infarct: a case-control study. Eur J Neurol 2016;23:1572-1579.
33.
Dogan S, Gunzer F, Guenay H, Hillmann G, Geurtsen W: Infection of primary human gingival fibroblasts by porphyromonas gingivalis and Prevotella intermedia. Clin Oral Investig 2000;4:35-41.
34.
Tribble GD, Lamont RJ: Bacterial invasion of epithelial cells and spreading in periodontal tissue. Periodontol 2000 2010;52:68-83.
35.
Riviere GR, Riviere KH, Smith KS: Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer's disease. Oral Microbiol Immunol 2002;17:113-118.
36.
Visser MB, Ellen RP: New insights into the emerging role of oral spirochaetes in periodontal disease. Clin Microbiol Infect 2011;17:502-512.
37.
Sparks Stein P, Steffen MJ, Smith C, Jicha G, Ebersole JL, Abner E, et al: Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease. Alzheimers Dement 2012;8:196-203.
38.
Noble JM, Borrell LN, Papapanou PN, Elkind MS, Scarmeas N, Wright CB: Periodontitis is associated with cognitive impairment among older adults: analysis of NHANES-III. J Neurol Neurosurg Psychiatry 2009;80:1206-1211.
39.
D'Aiuto F, Parkar M, Andreou G, Suvan J, Brett PM, Ready D, et al: Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 2004;83:156-160.
40.
Stein PS, Desrosiers M, Donegan SJ, Yepes JF, Kryscio RJ: Tooth loss, dementia and neuropathology in the Nun study. J Am Dent Assoc 2007;138:1314-1322; quiz 1381-1382.
41.
Stein S, Scheff S, Dawson DR: Alzheimer's disease and periodontal disease: mechanisms underlying a potential bidirectional relationship. Grand Rounds Oral Syst Med 2006;1:14-24.
42.
Ghezzi EM, Ship JA: Dementia and oral health. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:2-5.
43.
Henriksen BM, Engedal K, Axéll T: Cognitive impairment is associated with poor oral health in individuals in long-term care. Oral Health Prev Dent 2005;3:203-207.
44.
Chalmers JM, Carter KD, Spencer AJ: Oral diseases and conditions in community-living older adults with and without dementia. Spec Care Dentist 2003;23:7-17.
45.
Holtfreter B, Albandar JM, Dietrich T, Dye BA, Eaton KA, Eke PI, et al; Joint EU/USA Periodontal Epidemiology Working Group: Standards for reporting chronic periodontitis prevalence and severity in epidemiologic studies: proposed standards from Joint EU/USA Periodontal Epidemiology Working Group. J Clin Periodontol 2015;42:407-412.
46.
Hill AB: The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.